SCHEMBL6441345

SCHEMBL6441345

CS(=O)(=O)c1ccc(-c2cc(CC(=O)CCO[N+](=O)[O-])nn2C2CCCCC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.73
PTGS1 P23219 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3868775 0.87 PTGS2 (0.81) PTGS2PTGS1
SCHEMBL6441090 0.87 PTGS2 (0.63) PTGS2PTGS1
SCHEMBL3872814 0.86 PTGS2 (0.80) PTGS2PTGS1
SCHEMBL3863213 0.85 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL3869713 0.85 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL3864347 0.84 PTGS2 (0.83) PTGS2PTGS1
SCHEMBL3865180 0.84 PTGS2 (0.83) PTGS2PTGS1
SCHEMBL3867770 0.83 PTGS2 (0.66) PTGS2PTGS1
SCHEMBL3865233 0.79 PTGS2 (0.71) PTGS2PTGS1
SCHEMBL3865904 0.79 PTGS2 (0.71) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534683-A4 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2005-08-24 EP disclosed
EP-1534683-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-01 EP disclosed
WO-2004002409-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-01-08 WO disclosed